Digital Breast Mammography and Contrast Enhanced Mammography - Case 7 - USA

Case #7 A 43 year old lady who attended at our institution because of a pulpable lamp in the left breast. Well. On the conventional study, we detected a well eliminated well circumscribed mass on the left breast, both cranial codal and MLO views. After the administration of contrast medium, we see there is not an uptake of contrast on this mass and this is typical of a benign lesion such a fibroadenoma. This was the correlation with ultrasound, the mass and the biopsy confirmed of fibroadenoma. So in this case, Tyson was very useful to predict the benignity of a palpable breast lamp before the biopsy was performed.

13 cima Case 7 Digital Mammography and Contrast Enhanced Mammography Prof. Dr. Luis Pina NIVERSITAS ENSIS Breast Imaging Department (Radiología mamaria) Clínica Clínica Universidad de Navarra Universidad Pamplona, Spain de Navarra ARR Server: VIASRV Administrator R_Case_07, Pina * 1/1/1974 F Reading_2018 Series MG Breast Add Study MG Reading TOMO LCC First Step Previous Quadrant INSIGHT CEM_LC LCC LE IN SIGHT CEM LM LMLO LE LO CC 4 Findings TOMO RCC INSIGHT CEM_RC Tools Reset RMLO LE 9:02 AM tion Hide Clinical information 43-year-old lady Palpable lump (left breast) MG SIEMENS Lock INSIGHT CEM_RM Prof. Pina CEM Next NSIGHT CEM_RC INSIGHT_CEM_RM ReportFlow Prof. Pina CEM image to NSIGHT 2D RCC INSIGHT CEM LM Ultrasound B RES-B P 52mm PRC 11/3/1 PRS PST 2 DR. PINA LA523 D1 2.51 cm IN XV 6 FFDM Pathology Fibroadenoma useful he Learnings TiCEM was useful to predict the benignity of a palpable breast lump Siemens Healthineers AG, 2024 Please note: This learning material is for training purposes only. Please note: Some functions shown in this material are optional and might not be part of your system. Certain products, product related claims or functionalities (hereinafter collectively "Functionality") may not (yet) be commercially available in your country. Due to regulatory requirements, the availability of said Functionalities in any specific country is not guaranteed. Please contact your local Siemens Healthineers sales representative for the most current information. The reproduction, transmission or distribution of this training or its contents is not permitted without express written authority. Offenders will be liable for damages. The statements by customers of Siemens Healthineers described herein are based on results that were achieved in the customer's unique setting. Because there is no "typical" hospital or laboratory and many variables exist (e.g ., hospital size, samples mix, case mix, level of IT and/or automation adoption) there can be no guarantee that other customers will achieve the same results. The speakers and/or their employer receive financial support from Siemens Healthineers for collaborations. All rights, including rights created by patent grant or registration of a utility model or design, are reserved. Healthineers